Dopamine Receptor D2 (DRD2) Antibody,Abbexa,abx029030
This gene encodes the D2 subtype of the dopamine receptor. This G-protein coupled receptor inhibits adenylyl cyclase activity. A missense mutation in this gene causes myoclonus dystonia; other mutations have been associated with schizophrenia. Alternative splicing of this gene results in two transcript variants encoding different isoforms. A third variant has been described, but it has not been determined whether this form is normal or due to aberrant splicing.
Host
Rabbit
Reactivity
Human
Application
ELISA, WB
Conjugate
Unconjugated
Platform ID
BAB206483124

Abbexa
Contact
Tel: +44 (0) 1223 755950
Fax: +44 (0) 1223 755951
Email:
Product Specifications
Specifications
NameDopamine Receptor D2 (DRD2) Antibody
Cat. No.abx029030
Accession NumberP14416
Gene ID (Entrez)1813
HostRabbit
IsotypeIgG
ReactivityHuman
ConjugationUnconjugated
ApplicationELISA, WB
Working DilutionsWB: 1/2000. Optimal dilutions/concentrations should be determined by the end user.
ClonalityPolyclonal
Concentration0.5 mg/ml
Molecular WeightCalculated MW: 50.6 kDa
TargetDRD2
ImmunogenKLH-conjugated synthetic peptide between 307-336 amino acids from the C-terminal region of human DRD2.
PurityPurified through a protein A column, followed by peptide affinity purification.
Appearance/FormLiquid
FormulationPBS containing 0.09% sodium azide.
StorageAliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Regulatory StatusResearch Use Only
Category Paths
- Products>Primary Antibodies>Polyclonal Antibodies
Request a product
Please provide the required information below so that we can quickly source your products.
